130 related articles for article (PubMed ID: 3879782)
21. Role of protein adsorption on haemodialysis-induced complement activation and neutrophil defects.
Neveceral P; Markert M; Wauters JP
Nephrol Dial Transplant; 1995; 10(3):372-6. PubMed ID: 7792033
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo model of hemodialysis membrane biocompatibility.
Spencer PC; Schmidt B; Samtleben W; Bosch T; Gurland HJ
Trans Am Soc Artif Intern Organs; 1985; 31():495-8. PubMed ID: 3879781
[No Abstract] [Full Text] [Related]
23. [Complement activation in patients with chronic polyarthritis, measured by the level of complement fraction C3a in plasma].
Kapp A; Meske-Brand S; Maly FE; Müller W
Z Rheumatol; 1984; 43(3):103-5. PubMed ID: 6332437
[TBL] [Abstract][Full Text] [Related]
24. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
Wegmüller E; Montandon A; Nydegger U; Descoeudres C
Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
[TBL] [Abstract][Full Text] [Related]
25. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis.
van Wyk V; Badenhorst PN; Kotzé HF
Clin Nephrol; 1997 Dec; 48(6):381-7. PubMed ID: 9438098
[TBL] [Abstract][Full Text] [Related]
26. Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes.
Stannat S; Bahlmann J; Kiessling D; Koch KM; Deicher H; Peter HH
Contrib Nephrol; 1985; 46():102-8. PubMed ID: 3874042
[No Abstract] [Full Text] [Related]
27. Studies of biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate.
Haag-Weber M; Mai B; Deppisch R; Göhl H; Hörl WH
Clin Nephrol; 1994 Apr; 41(4):245-51. PubMed ID: 8026120
[TBL] [Abstract][Full Text] [Related]
28. Biocompatibility of dialyser membranes: roles of membranes and of patients.
Pengloan J; Petit A; Thibaut G; Blanchier D; Bardos P
Nephrol Dial Transplant; 1991; 6 Suppl 2():59-60. PubMed ID: 1866070
[No Abstract] [Full Text] [Related]
29. Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes.
Moss AH; Hamrick RM; Shen SH
ASAIO Trans; 1989; 35(4):812-5. PubMed ID: 2611049
[TBL] [Abstract][Full Text] [Related]
30. Complement activation is influenced by the membrane material, design of the dialyser, sterilizing method, and type of dialysate.
Lundberg L; Johansson G; Karlsson L; Stegmayr BG
Nephrol Dial Transplant; 1994; 9(9):1310-4. PubMed ID: 7816297
[TBL] [Abstract][Full Text] [Related]
31. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
32. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure.
Bosch T; Thiery J; Gurland HJ; Seidel D
Nephrol Dial Transplant; 1993; 8(12):1350-8. PubMed ID: 8159304
[TBL] [Abstract][Full Text] [Related]
33. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.
Böhler J; Schollmeyer P; Dressel B; Dobos G; Hörl WH
J Am Soc Nephrol; 1996 Feb; 7(2):234-41. PubMed ID: 8785392
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
[TBL] [Abstract][Full Text] [Related]
35. Ultrafiltration and endotoxin removal from dialysis fluids.
Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
[TBL] [Abstract][Full Text] [Related]
36. [Immediate effect of hemodialysis with cuprophane membrane and acetate containing dialysis fluid on respiratory function in patients with chronic renal failure].
Wanic-Kossowska M
Pol Tyg Lek; 1993 Feb 15-22; 48(7-8):175-7. PubMed ID: 8415262
[TBL] [Abstract][Full Text] [Related]
37. Symptoms and activation of granulocytes and complement with two dialysis membranes.
Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268
[TBL] [Abstract][Full Text] [Related]
38. The influence of dialyzer geometry on blood coagulation and biocompatibility.
Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
[TBL] [Abstract][Full Text] [Related]
39. Complement activation and neutrophil aggregation changes during haemodialysis.
Kubatiev A; Rudko I; Ermolenko V
Int J Clin Pharmacol Res; 1993; 13(6):293-9. PubMed ID: 8088929
[TBL] [Abstract][Full Text] [Related]
40. Blood flow dependent granulocyte activation in membranes with and without complement activation.
Böhler J; Donauer J; Schollmeyer P; Hörl WH
Adv Exp Med Biol; 1991; 297():215-24. PubMed ID: 1767753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
